NRXS
NeurAxis, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.96
−1.81%Margins
Gross margin
85.6%
EBITDA margin
-141.1%
EBIT margin
-144.5%
Net margin
-148.0%
FCF margin
-106.0%
-116.9%
Return on equity
-78.7%
Return on assets
-109.5%
Return on invested capital
0.57x
Asset turnover
-$5.6M
Cash from operations
$0.66
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026